Millennium Management
CCEL icon

Millennium Management’s Cryo-Cell International CCEL Stock Holding History

Millennium Management’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,741
Closed -$148K – 6947
2021
Q4 		$148K Buy
+12,741
New +$159K ﹤0.01% 6078

Other funds holding CCEL

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
MCM
Maryland Capital Management Towson, Maryland $1.2B AUM 18.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Millennium Management's CCEL Position: Q1 2022 in Review

Millennium Management sold out of Cryo-Cell International (CCEL) in Q1 2022, closing a stake of 12,741 shares — an estimated $148K sold.

Millennium Management first reported a position in CCEL in Q4 2021 and held it in 1 quarter. The position peaked at $148K in Q4 2021. 12 funds tracked by Wall St. Rank hold CCEL as of Q1 2022.

  • Millennium Management reported no remaining Cryo-Cell International position as of Q1 2022 after selling out during the quarter.
  • Millennium Management sold 12,741 Cryo-Cell International shares in Q1 2022, an estimated $148K.
  • Millennium Management first reported a position in Cryo-Cell International in Q4 2021 and held it in 1 quarter.
  • Millennium Management's Cryo-Cell International position peaked at $148K in Q4 2021.
  • 12 funds tracked by Wall St. Rank held Cryo-Cell International as of Q1 2022.

Based on Millennium Management's 13F filing for Q1 2022, filed 16 May 2022.